StartsideALNOV • EPA
add
Novacyt SA
Forrige sluttkurs
0,75 €
Dagsintervall
0,72 € - 0,76 €
Årsintervall
0,45 € - 1,59 €
Markedsverdi
52,18 mill. EUR
Gjennomsnittlig volum
2,09 mill.
P/E-tall
-
Utbytte
-
Hovedbørs
EPA
Markedsnyheter
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
| (GBP) | des. 2023info | Endring år til år |
|---|---|---|
Omsetning | 4,12 mill. | 81,82 % |
Driftskostnader | 12,52 mill. | 48,31 % |
Nettoomsetning | −9,97 mill. | −17,10 % |
Netto resultatmargin | −242,04 | 35,59 % |
Fortjeneste per aksje | — | — |
EBITDA | −7,10 mill. | −41,10 % |
Faktisk avgiftssats | 2,93 % | — |
Balanseregnskap
Totale aktiva
Totale passiva
| (GBP) | des. 2023info | Endring år til år |
|---|---|---|
Kontant / kortsiktige inv. | 44,06 mill. | −49,34 % |
Totale aktiva | 133,82 mill. | −5,03 % |
Totale passiva | 46,57 mill. | 81,32 % |
Total egenkapital | 87,24 mill. | — |
Utestående aksjer | 70,63 mill. | — |
P/B-forhold | 0,60 | — |
Avkastning på aktiva | −21,46 % | — |
Avkastning på kapital | −28,44 % | — |
Kontantstrøm
Netto kontantstrøm
| (GBP) | des. 2023info | Endring år til år |
|---|---|---|
Nettoomsetning | −9,97 mill. | −17,10 % |
Kontantstrøm fra drift | −9,65 mill. | −59,94 % |
Kontanter fra investering | −7,47 mill. | −3 853,70 % |
Kontanter fra finansiering | −1,72 mill. | −1 360,85 % |
Netto kontantstrøm | −18,84 mill. | −197,44 % |
Fri kontantstrøm | −3,81 mill. | −56,02 % |
Om
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying an extensive range assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Administrerende direktør
Grunnlagt
2006
Nettsted
Ansatte
237
